{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:05:22Z","timestamp":1789718722752,"version":"4.0.1"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["7R01AI150381-02"],"award-info":[{"award-number":["7R01AI150381-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["DISC2-13510"],"award-info":[{"award-number":["DISC2-13510"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007557","name":"California Institute of Regenerative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007557","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.clim.2023.109741","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T11:36:29Z","timestamp":1692617789000},"page":"109741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Antiretrovirals to CCR5 CRISPR\/Cas9 gene editing - A paradigm shift chasing an HIV cure"],"prefix":"10.1016","volume":"255","author":[{"given":"Amber","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandagopal","family":"Paneerselvam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2023.109741_bb0015","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1600693","article-title":"Antiretroviral Therapy for the Prevention of HIV-1 Transmission","volume":"375","author":"Cohen","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2023.109741_bb0025","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/infdis\/jit107","article-title":"Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings","volume":"207","author":"Hosseinipour","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2023.109741_bb0030","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tins.2020.06.007","article-title":"The paradox of HIV blood\u2013brain barrier penetrance and antiretroviral drug delivery deficiencies","volume":"43","author":"Osborne","year":"2020","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.clim.2023.109741_bb0035","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57246","article-title":"The HIV-1 latent reservoir is largely sensitive to circulating T cells","volume":"9","author":"Warren","year":"2020","journal-title":"ELife."},{"key":"10.1016\/j.clim.2023.109741_bb0040","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science."},{"key":"10.1016\/j.clim.2023.109741_bb0045","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/8394","article-title":"Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy","volume":"5","author":"Finzi","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2023.109741_bb0050","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/31405","article-title":"Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody","volume":"393","author":"Kwong","year":"1998","journal-title":"Nature."},{"key":"10.1016\/j.clim.2023.109741_bb0055","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/381661a0","article-title":"Identification of a major co-receptor for primary isolates of HIV-1","volume":"381","author":"Deng","year":"1996","journal-title":"Nature."},{"key":"10.1016\/j.clim.2023.109741_bb0060","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/382722a0","article-title":"Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene","volume":"382","author":"Samson","year":"1996","journal-title":"Nature."},{"key":"10.1016\/j.clim.2023.109741_bb0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1515\/med-2018-0062","article-title":"The CCR5-Delta32 genetic polymorphism and HIV-1 infection susceptibility: a meta-analysis","volume":"13","author":"Ni","year":"2018","journal-title":"Open Med."},{"key":"10.1016\/j.clim.2023.109741_bb0070","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"H\u00fctter","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2023.109741_bb0075","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 remission following CCR5\u039432\/\u039432 haematopoietic stem-cell transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature."},{"key":"10.1016\/j.clim.2023.109741_bb0085","first-page":"1","article-title":"In-depth virological and immunological characterization of HIV-1 cure after CCR5\u039432\/\u039432 allogeneic hematopoietic stem cell transplantation","author":"Jensen","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2023.109741_bb0090","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.cell.2023.02.030","article-title":"HIV-1 remission and possible cure in a woman after haplo-cord blood transplant","volume":"186","author":"Hsu","year":"2023","journal-title":"Cell."},{"key":"10.1016\/j.clim.2023.109741_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.647688","article-title":"Epigenetic features of HIV-induced T-cell exhaustion persist despite early antiretroviral therapy","volume":"12","author":"Martin","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2023.109741_bb0105","series-title":"WHO Clinical Staging of HIV Disease in Adults, Adolescents and Children","year":"2016"},{"key":"10.1016\/j.clim.2023.109741_bb0115","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.apsb.2021.11.009","article-title":"Approved HIV reverse transcriptase inhibitors in the past decade","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.clim.2023.109741_bb0120","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/CMR.11.4.614","article-title":"Protease inhibitors as antiviral agents","volume":"11","author":"Patick","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.clim.2023.109741_bb0125","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1517\/13543776.2011.550876","article-title":"Small molecule HIV entry inhibitors: Part II. Attachment and fusion inhibitors: 2004-2010","volume":"21","author":"Singh","year":"2011","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.clim.2023.109741_bb0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00001432-200402000-00003","article-title":"Co-receptor antagonists as HIV-1 entry inhibitors","volume":"17","author":"Shaheen","year":"2004","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.clim.2023.109741_bb0135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12977-022-00608-1","article-title":"A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection","volume":"19","author":"Zhao","year":"2022","journal-title":"Retrovirology."},{"key":"10.1016\/j.clim.2023.109741_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114078","article-title":"Recent research results have converted gp120 binders to a therapeutic option for the treatment of HIV-1 infection. A medicinal chemistry point of view","volume":"229","author":"Governa","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.clim.2023.109741_bb0145","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/1062936X.2021.1901310","article-title":"E-pharmacophore based screening to identify potential HIV-1 gp120 and CD4 interaction blockers for wild and mutant types","volume":"32","author":"Chandra","year":"2021","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.clim.2023.109741_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12981-022-00499-4","article-title":"Safety and efficacy of switching to elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate in treatment-experienced people with HIV: a multicenter cohort study","volume":"20","author":"De Castro","year":"2023","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.clim.2023.109741_bb0155","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1080\/03007995.2022.2088714","article-title":"Comorbidity and comedication burden among people living with HIV in the United States","volume":"38","author":"Paudel","year":"2022","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.clim.2023.109741_bb0160","first-page":"229","article-title":"Adverse effects of antiretroviral therapy for HIV infection","volume":"170","author":"Montessori","year":"2004","journal-title":"CMAJ Can. Med. Assoc. J."},{"key":"10.1016\/j.clim.2023.109741_bb0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/v12030297","article-title":"The determination of HIV-1 RT mutation rate, its possible allosteric effects, and its implications on drug resistance","volume":"12","author":"Yeo","year":"2020","journal-title":"Viruses."},{"key":"10.1016\/j.clim.2023.109741_bb0170","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/COH.0000000000000536","article-title":"Phylogenetics in HIV transmission: taking within-host diversity into account","volume":"14","author":"Leitner","year":"2019","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.clim.2023.109741_bb0175","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3390\/v14081761","article-title":"HIV-1 Diversity and drug resistance in treatment-Na\u00efve children and adolescents from Rio de Janeiro, Brazil","volume":"14","author":"de Azevedo","year":"2022","journal-title":"Viruses."},{"key":"10.1016\/j.clim.2023.109741_bb0180","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1098\/rsif.2012.0127","article-title":"Assessing the impact of adherence to anti-retroviral therapy on treatment failure and resistance evolution in HIV","volume":"9","author":"Cadosch","year":"2012","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.clim.2023.109741_bb0185","doi-asserted-by":"crossref","first-page":"e2610","DOI":"10.1212\/WNL.0000000000010752","article-title":"Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis","volume":"95","author":"Wang","year":"2020","journal-title":"Neurology."},{"key":"10.1016\/j.clim.2023.109741_bb0190","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03633-20","article-title":"Central nervous system (CNS) viral seeding by mature monocytes and potential therapies to reduce CNS viral reservoirs in the cART era","volume":"12","author":"Le\u00f3n-Rivera","year":"2021","journal-title":"MBio."},{"key":"10.1016\/j.clim.2023.109741_bb0195","first-page":"552","article-title":"Nef inhibits HIV transcription and gene expression in astrocytes and HIV transmission from astrocytes to CD4+ T cells","volume":"28","author":"Kandel","year":"2022","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.clim.2023.109741_bb0200","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01280-17","article-title":"Mechanisms of CNS viral seeding by HIV+ CD14+ CD16+ monocytes: establishment and reseeding of viral reservoirs contributing to HIV-associated neurocognitive disorders","volume":"8","author":"Veenstra","year":"2017","journal-title":"MBio."},{"key":"10.1016\/j.clim.2023.109741_bb0205","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3390\/v14040829","article-title":"Characterization of HIV-1 infection in microglia-containing human cerebral organoids","volume":"14","author":"Gumbs","year":"2022","journal-title":"Viruses."},{"key":"10.1016\/j.clim.2023.109741_bb0210","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/QAD.0000000000000605","article-title":"Cell-to-cell contact facilitates HIV transmission from lymphocytes to astrocytes via CXCR4","volume":"29","author":"Li","year":"2015","journal-title":"AIDS Lond. Engl."},{"key":"10.1016\/j.clim.2023.109741_bb0215","doi-asserted-by":"crossref","first-page":"39738","DOI":"10.1038\/srep39738","article-title":"Antiretroviral treatment with efavirenz disrupts the blood-brain barrier integrity and increases stroke severity","volume":"6","author":"Bertrand","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2023.109741_bb0220","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.biopha.2017.07.067","article-title":"Efavirenz loaded nanostructured lipid carrier engineered for brain targeting through intranasal route: In-vivo pharmacokinetic and toxicity study","volume":"94","author":"Pokharkar","year":"2017","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"10.1016\/j.clim.2023.109741_bb0225","doi-asserted-by":"crossref","first-page":"e02213","DOI":"10.1128\/AAC.02213-16","article-title":"Pharmacokinetics and placental transfer of Elvitegravir, Dolutegravir, and other antiretrovirals during pregnancy","volume":"61","author":"Rimawi","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.clim.2023.109741_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233341","article-title":"National-level effectiveness of ART to prevent early mother to child transmission of HIV in Namibia","volume":"15","author":"Agabu","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2023.109741_bb0235","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)80694-7","article-title":"DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells","volume":"100","author":"Geijtenbeek","year":"2000","journal-title":"Cell."},{"key":"10.1016\/j.clim.2023.109741_bb0240","doi-asserted-by":"crossref","first-page":"19464","DOI":"10.1073\/pnas.0703747104","article-title":"Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1","volume":"104","author":"de Witte","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2023.109741_bb0245","article-title":"Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides","volume":"10","author":"Izquierdo-Useros","year":"2012","journal-title":"PLoS Biol."},{"key":"10.1016\/j.clim.2023.109741_bb0250","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1126\/science.2171144","article-title":"Retroviral DNA integration directed by HIV integration protein in vitro","volume":"249","author":"Bushman","year":"1990","journal-title":"Science."},{"key":"10.1016\/j.clim.2023.109741_bb0255","first-page":"1341","article-title":"Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection","volume":"151","author":"Rottman","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.clim.2023.109741_bb0260","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.virol.2017.12.025","article-title":"Protein S and Gas6 induce efferocytosis of HIV-1-infected cells","volume":"515","author":"Chua","year":"2018","journal-title":"Virology."},{"issue":"205","key":"10.1016\/j.clim.2023.109741_bb0265","first-page":"2726","article-title":"Role of tunneling nanotube (TNT)-like structures during the early events of HIV-infection: novel features of tissue compartmentalization and mechanism of HIV spread","volume":"1950","author":"Okafo","year":"2020","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.clim.2023.109741_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006181","article-title":"Siglec-1 initiates formation of the virus-containing compartment and enhances macrophage-to-T cell transmission of HIV-1","volume":"13","author":"Hammonds","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.clim.2023.109741_bb0275","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1096\/fj.09-151704","article-title":"Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain","volume":"24","author":"Wexler-Cohen","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.clim.2023.109741_bb0280","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12977-019-0464-3","article-title":"Sequential trafficking of Env and Gag to HIV-1 T cell virological synapses revealed by live imaging","volume":"16","author":"Wang","year":"2019","journal-title":"Retrovirology"},{"key":"10.1016\/j.clim.2023.109741_bb0285","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/01.qai.0000532597.67178.f2","article-title":"D-105 reversible HIV-1 latency induced in primary human monocyte-derived macrophages by repeated M1 polarization","volume":"77","author":"Graziano","year":"2018","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.clim.2023.109741_bb0290","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.chom.2012.07.011","article-title":"Tetherin\/BST-2 is essential for the formation of the intracellular virus-containing compartment in HIV-infected macrophages","volume":"12","author":"Chu","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.clim.2023.109741_bb0295","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1038\/s41467-021-22375-x","article-title":"Human anogenital monocyte-derived dendritic cells and langerin+cDC2 are major HIV target cells","volume":"12","author":"Rhodes","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2023.109741_bb0300","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm.1972","article-title":"HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation","volume":"15","author":"Chomont","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2023.109741_bb0305","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1084\/jem.188.1.83","article-title":"Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines","volume":"188","author":"Chun","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2023.109741_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008194","article-title":"TGF-\u03b2 and IL-10 production by HIV-specific CD8+ T CELLS is regulated by CTLA-4 signaling on CD4+ T cells","volume":"4","author":"Elrefaei","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2023.109741_bb0315","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm.2106","article-title":"Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection","volume":"16","author":"Said","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2023.109741_bb0320","doi-asserted-by":"crossref","first-page":"16934","DOI":"10.1073\/pnas.1002894107","article-title":"Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton","volume":"107","author":"Cameron","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2023.109741_bb0325","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1084\/jem.189.11.1735","article-title":"Cytokine Signals Are Sufficient for HIV-1 Infection of Resting Human T Lymphocytes","volume":"189","author":"Unutmaz","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2023.109741_bb0330","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1084\/jem.20061681","article-title":"Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells","volume":"204","author":"Riou","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2023.109741_bb0335","doi-asserted-by":"crossref","first-page":"30662","DOI":"10.1074\/jbc.272.49.30662","article-title":"The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5\u2032-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons","volume":"272","author":"Mummidi","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2023.109741_bb0340","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41590-019-0406-1","article-title":"CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome","volume":"20","author":"Kulkarni","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2023.109741_bb0345","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1089\/aid.2020.0060","article-title":"New knowledge about CCR5, HIV infection, and disease progression: is \u201cold\u201d still valuable?","volume":"36","author":"Mehlotra","year":"2020","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.clim.2023.109741_bb0350","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cyto.2018.02.018","article-title":"CCR5: Established paradigms and new frontiers for a \u201ccelebrity\u201d chemokine receptor","volume":"109","author":"Scurci","year":"2018","journal-title":"Cytokine."},{"key":"10.1016\/j.clim.2023.109741_bb0355","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1073\/pnas.94.8.4005","article-title":"Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virusstrains","volume":"94","author":"Edinger","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.clim.2023.109741_bb0360","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0166-1280(99)00393-0","article-title":"Structure analysis of CCR5 from human and primates","volume":"505","author":"Yang","year":"2000","journal-title":"J. Mol. Struct. THEOCHEM"},{"key":"10.1016\/j.clim.2023.109741_bb0365","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jmb.2006.10.040","article-title":"Recognition of RANTES by extracellular parts of the CCR5 receptor","volume":"365","author":"Duma","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.clim.2023.109741_bb0370","doi-asserted-by":"crossref","first-page":"16228","DOI":"10.1074\/jbc.274.23.16228","article-title":"Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 co-receptor and ligand binding function*","volume":"274","author":"Howard","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2023.109741_bb0375","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.1241475","article-title":"Structure of the CCR5 chemokine receptor\u2013HIV entry inhibitor maraviroc complex","volume":"341","author":"Tan","year":"2013","journal-title":"Science."},{"key":"10.1016\/j.clim.2023.109741_bb0380","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1083\/jcb.151.6.1281","article-title":"Endocytosis and recycling of the HIV coreceptor CCR5","volume":"151","author":"Signoret","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.clim.2023.109741_bb0385","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1111\/febs.16328","article-title":"Multiple binding modes of an N-terminal CCR5-peptide in complex with HIV-1 gp120","volume":"289","author":"Moseri","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.clim.2023.109741_bb0390","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3390\/v13071395","article-title":"Modeling of CCR5 recognition by HIV-1 gp120: how the viral protein exploits the conformational plasticity of the coreceptor","volume":"13","author":"Jacquemard","year":"2021","journal-title":"Viruses."},{"key":"10.1016\/j.clim.2023.109741_bb0395","doi-asserted-by":"crossref","first-page":"30603","DOI":"10.1074\/jbc.272.49.30603","article-title":"Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5\u039432*","volume":"272","author":"Benkirane","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2023.109741_bb0400","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1074\/jbc.274.4.1905","article-title":"A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1*","volume":"274","author":"Siciliano","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2023.109741_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0030339","article-title":"The geographic spread of the CCR5 \u039432 HIV-resistance allele","volume":"3","author":"Novembre","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.clim.2023.109741_bb0410","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tree.2004.02.001","article-title":"Allelic histories: positive selection on a HIV-resistance allele","volume":"19","author":"Stumpf","year":"2004","journal-title":"Trends Ecol. Evol."},{"key":"10.1016\/j.clim.2023.109741_bb0415","first-page":"201","article-title":"Frequencies of 32 base pair deletion of the (Delta 32) allele of the CCR5 HIV-1 co-receptor gene in Caucasians: a comparative analysis","volume":"1","author":"Lucotte","year":"2002","journal-title":"Infect. Genet. Evol. J. Mol. Epidemiol. Evol. Genet. Infect. Dis."},{"key":"10.1016\/j.clim.2023.109741_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00295","article-title":"CCR5 and HIV infection, a view from Brussels","volume":"6","author":"Parmentier","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2023.109741_bb0425","doi-asserted-by":"crossref","first-page":"15276","DOI":"10.1073\/pnas.2435085100","article-title":"Evaluating plague and smallpox as historical selective pressures for the CCR5-\u039432 HIV-resistance allele","volume":"100","author":"Galvani","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.clim.2023.109741_bb0430","doi-asserted-by":"crossref","first-page":"111","DOI":"10.33549\/physiolres.934647","article-title":"CCR5Delta32 deletion as a protective factor in Czech first-wave COVID-19 subjects","volume":"70","author":"Hubacek","year":"2021","journal-title":"Physiol. Res."},{"key":"10.1016\/j.clim.2023.109741_bb0435","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01962-21","article-title":"Blockade of autocrine CCL5 responses inhibits Zika virus persistence and spread in human brain microvascular endothelial cells","volume":"12","author":"Mladinich","year":"2021","journal-title":"MBio."},{"key":"10.1016\/j.clim.2023.109741_bb0440","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/imm.12476","article-title":"Dengue virus requires the CC-chemokine receptor CCR5 for replication and infection development","volume":"145","author":"Marques","year":"2015","journal-title":"Immunology."},{"key":"10.1016\/j.clim.2023.109741_bb0445","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1034\/j.1399-0039.2001.580302.x","article-title":"Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy","volume":"58","author":"Calzada","year":"2001","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.clim.2023.109741_bb0450","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.cell.2019.01.044","article-title":"CCR5 Is a therapeutic target for recovery after stroke and traumatic brain injury","volume":"176","author":"Joy","year":"2019","journal-title":"Cell."},{"key":"10.1016\/j.clim.2023.109741_bb0455","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20051970","article-title":"CCR5 deficiency increases risk of symptomatic West Nile virus infection","volume":"203","author":"Glass","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2023.109741_bb0460","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1099\/vir.0.000165","article-title":"CCR5 deficiency predisposes to fatal outcome in influenza virus infection","volume":"96","author":"Falcon","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.clim.2023.109741_bb0465","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/s41467-017-02368-5","article-title":"The HIV co-receptor CCR5 regulates osteoclast function","volume":"8","author":"Lee","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2023.109741_bb0470","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1182\/hematology.2022000327","article-title":"In 2022, which is preferred: haploidentical or cord transplant?","volume":"2022","author":"Nagler","year":"2022","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"10.1016\/j.clim.2023.109741_bb0475","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.bbmt.2017.03.036","article-title":"Cryopreserved CD34+ cell dose, but not total nucleated cell dose, influences hematopoietic recovery and extensive chronic graft-versus-host disease after single-unit cord blood transplantation in adult patients","volume":"23","author":"Konuma","year":"2017","journal-title":"Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant."},{"key":"10.1016\/j.clim.2023.109741_bb0480","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4161\/chim.1.1.12141","article-title":"Double unit cord blood transplantation: Who wins-and why do we care?","volume":"1","author":"Gutman","year":"2010","journal-title":"Chimerism."},{"key":"10.1016\/j.clim.2023.109741_bb0485","doi-asserted-by":"crossref","first-page":"15866","DOI":"10.1038\/s41598-020-71699-z","article-title":"Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection","volume":"10","author":"Connell","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2023.109741_bb0490","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1128\/JVI.73.8.6680-6690.1999","article-title":"Patterns of chemokine receptor fusion cofactor utilization by human immunodeficiency virus type 1 variants from the lungs and blood","volume":"73","author":"Singh","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2023.109741_bb0495","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00193-20","article-title":"Existence of replication-competent minor variants with different coreceptor usage in plasma from HIV-1-infected individuals","volume":"94","author":"Maeda","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2023.109741_bb0500","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1099\/vir.0.81722-0","article-title":"Purifying selection of CCR5-tropic human immunodeficiency virus type 1 variants in AIDS subjects that have developed syncytium-inducing, CXCR4-tropic viruses","volume":"87","author":"Fern\u00e0ndez","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.clim.2023.109741_bb0505","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature24633","article-title":"Origin and differentiation of human memory CD8 T cells after vaccination","volume":"552","author":"Akondy","year":"2017","journal-title":"Nature."},{"key":"10.1016\/j.clim.2023.109741_bb0510","article-title":"High CCR5 density on central memory CD4+ T cells in acute HIV-1 infection is mostly associated with rapid disease progression","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2023.109741_bb0515","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1086\/431519","article-title":"Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals","volume":"192","author":"Brumme","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2023.109741_bb0520","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa1817426","article-title":"CRISPR-edited stem cells in a patient with HIV and acute lymphocytic leukemia","volume":"381","author":"Xu","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2023.109741_bb0525","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/cr.2016.142","article-title":"CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells","volume":"27","author":"Liu","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.clim.2023.109741_bb0530","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science."},{"key":"10.1016\/j.clim.2023.109741_bb0535","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature13011","article-title":"DNA interrogation by the CRISPR RNA-guided endonuclease Cas9","volume":"507","author":"Sternberg","year":"2014","journal-title":"Nature."},{"key":"10.1016\/j.clim.2023.109741_bb0540","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41556-020-0472-5","article-title":"Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing","volume":"22","author":"Artegiani","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.clim.2023.109741_bb0545","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1631\/jzus.B2100196","article-title":"A high-efficiency and versatile CRISPR\/Cas9-mediated HDR-based biallelic editing system","volume":"23","author":"Li","year":"2022","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.clim.2023.109741_bb0550","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nature20565","article-title":"In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature."},{"key":"10.1016\/j.clim.2023.109741_bb0555","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41467-023-35870-0","article-title":"Development of a versatile nuclease prime editor with upgraded precision","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2023.109741_bb0560","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ymthe.2021.10.026","article-title":"Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editing","volume":"30","author":"Knipping","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.clim.2023.109741_bb0565","doi-asserted-by":"crossref","first-page":"18457","DOI":"10.1038\/s41598-020-75295-z","article-title":"Genome editing of CCR5 by CRISPR-Cas9 in Mauritian cynomolgus macaque embryos","volume":"10","author":"Schmidt","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2023.109741_bb0570","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1590\/1678-4685-gmb-2017-0065","article-title":"Comparison of the editing patterns and editing efficiencies of TALEN and CRISPR-Cas9 when targeting the human CCR5 gene","volume":"41","author":"Nerys-Junior","year":"2018","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.clim.2023.109741_bb0575","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.1073\/pnas.1407473111","article-title":"Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5\u039432 mutation confers resistance to HIV infection","volume":"111","author":"Ye","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2023.109741_bb0580","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2015.42","article-title":"CCR5 disruption in induced pluripotent stem cells using CRISPR\/Cas9 provides selective resistance of immune cells to CCR5-tropic HIV-1 virus","volume":"4","author":"Kang","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.clim.2023.109741_bb0585","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1016\/j.cell.2022.09.026","article-title":"Structural basis for Cas9 off-target activity","volume":"185","author":"Pacesa","year":"2022","journal-title":"Cell."},{"key":"10.1016\/j.clim.2023.109741_bb0590","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jbiotec.2019.05.306","article-title":"Active fusions of Cas9 orthologs","volume":"301","author":"Josipovi\u0107","year":"2019","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.clim.2023.109741_bb0595","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1534\/g3.116.029801","article-title":"mCAL: a new approach for versatile multiplex action of Cas9 using one sgRNA and Loci Flanked by a programmed target sequence","volume":"6","author":"Finnigan","year":"2016","journal-title":"G3 Bethesda Md."},{"key":"10.1016\/j.clim.2023.109741_bb0600","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13578-020-00444-w","article-title":"Genome editing of CCR5 by AsCpf1 renders CD4+T cells resistance to HIV-1 infection","volume":"10","author":"Liu","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.clim.2023.109741_bb0605","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","article-title":"A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells","volume":"24","author":"Vakulskas","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2023.109741_bb0610","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/nar\/gkac1147","article-title":"CRISPR-Cas9 recognition of enzymatically synthesized base-modified nucleic acids","volume":"51","author":"Yang","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.clim.2023.109741_bb0615","doi-asserted-by":"crossref","first-page":"16104","DOI":"10.1038\/s41598-019-52616-5","article-title":"Improved Cas9 activity by specific modifications of the tracrRNA","volume":"9","author":"Scott","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2023.109741_bb0620","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gky505","article-title":"qEva-CRISPR: a method for quantitative evaluation of CRISPR\/Cas-mediated genome editing in target and off-target sites","volume":"46","author":"Dabrowska","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.clim.2023.109741_bb0625","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1166\/jbn.2019.2720","article-title":"ZeoR: a candidate for assays testing enzymatic activities and off-target effects of gene-editing enzymes","volume":"15","author":"Xu","year":"2019","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.clim.2023.109741_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119711","article-title":"Ex vivo cell-based CRISPR\/Cas9 genome editing for therapeutic applications","volume":"234","author":"Li","year":"2020","journal-title":"Biomaterials."},{"key":"10.1016\/j.clim.2023.109741_bb0635","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.895713","article-title":"Viral vectors for the in vivo delivery of CRISPR components: advances and challenges","volume":"10","author":"Asmamaw Mengstie","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.clim.2023.109741_bb0640","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202153902","article-title":"Unexpected gene activation following CRISPR-Cas9-mediated genome editing","volume":"23","author":"Manj\u00f3n","year":"2022","journal-title":"EMBO Rep."},{"key":"10.1016\/j.clim.2023.109741_bb0645","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.stem.2022.09.001","article-title":"Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells","volume":"29","author":"Ferrari","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.clim.2023.109741_bb0650","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000302","article-title":"Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study)","volume":"2","author":"Jacobson","year":"2023","journal-title":"BMJ Med."},{"key":"10.1016\/j.clim.2023.109741_bb0655","doi-asserted-by":"crossref","first-page":"16304","DOI":"10.1038\/s41598-018-34601-6","article-title":"TRIAMF: a new method for delivery of cas9 ribonucleoprotein complex to human hematopoietic stem cells","volume":"8","author":"Yen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2023.109741_bb0660","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jbiotec.2021.07.006","article-title":"Simple, fast and efficient iTOP-mediated delivery of CRISPR\/Cas9 RNP in difficult-to-transduce human cells including primary T cells","volume":"338","author":"Kholosy","year":"2021","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.clim.2023.109741_bb0670","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.ymthe.2017.04.027","article-title":"CRISPR\/Cas9-mediated CCR5 ablation in human hematopoietic stem\/progenitor cells confers HIV-1 resistance in vivo","volume":"25","author":"Xu","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.clim.2023.109741_bb0675","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13578-020-00410-6","article-title":"CCR5-\u039432 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool","volume":"10","author":"Xu","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.clim.2023.109741_bb0680","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2217\/14796694.3.1.19","article-title":"AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent","volume":"3","author":"Cashen","year":"2007","journal-title":"Future Oncol. Lond. Engl."},{"key":"10.1016\/j.clim.2023.109741_bb0685","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13287-022-02802-6","article-title":"Efficacy of hematopoietic stem cell mobilization regimens in patients with hematological malignancies: a systematic review and network meta-analysis of randomized controlled trials","volume":"13","author":"Luo","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.clim.2023.109741_bb0690","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/stem.1799","article-title":"Type II interferon promotes differentiation of myeloid-biased hematopoietic stem cells","volume":"32","author":"Matatall","year":"2014","journal-title":"Stem Cells Dayt. Ohio"},{"key":"10.1016\/j.clim.2023.109741_bb0695","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1089\/scd.2010.0456","article-title":"Mesenchymal stem cells secreting angiopoietin-like-5 support efficient expansion of human hematopoietic stem cells without compromising their repopulating potential","volume":"20","author":"Khoury","year":"2011","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.clim.2023.109741_bb0700","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.immuni.2023.04.019","article-title":"Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaques","volume":"56","author":"Wu","year":"2023","journal-title":"Immunity."},{"key":"10.1016\/j.clim.2023.109741_bb0705","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12977-022-00604-5","article-title":"CRISPR\/Cas9 genome editing to create nonhuman primate models for studying stem cell therapies for HIV infection","volume":"19","author":"Schmidt","year":"2022","journal-title":"Retrovirology."},{"key":"10.1016\/j.clim.2023.109741_bb0710","doi-asserted-by":"crossref","first-page":"1031334","DOI":"10.3389\/fimmu.2022.1031334","article-title":"Antibody based conditioning for allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Saha","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2023.109741_bb0715","doi-asserted-by":"crossref","first-page":"36ra43","DOI":"10.1126\/scitranslmed.3000931","article-title":"RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma","volume":"2","author":"DiGiusto","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.clim.2023.109741_bb0720","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2023.109741_bb0725","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144486","article-title":"CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication","volume":"131","author":"Tebas","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2023.109741_bb0730","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115987","article-title":"CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2023.109741_bb0735","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1099\/vir.0.000139","article-title":"Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR\/Cas9","volume":"96","author":"Li","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.clim.2023.109741_bb0740","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/gt.2016.27","article-title":"Lentivirus pre-packed with Cas9 protein for safer gene editing","volume":"23","author":"Choi","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.clim.2023.109741_bb0745","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.celrep.2016.09.080","article-title":"A Cas9 ribonucleoprotein platform for functional genetic studies of HIV-host interactions in primary human T cells","volume":"17","author":"Hultquist","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.clim.2023.109741_bb0750","doi-asserted-by":"crossref","first-page":"17113","DOI":"10.1038\/s41598-017-17180-w","article-title":"CRISPR\/Cas9 delivery with one single adenoviral vector devoid of all viral genes","volume":"7","author":"Ehrke-Schulz","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2023.109741_bb0755","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.omtn.2018.05.012","article-title":"Inducing CCR5\u039432\/\u039432 homozygotes in the human Jurkat CD4+ cell line and primary CD4+ cells by CRISPR-Cas9 genome-editing technology","volume":"12","author":"Qi","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.clim.2023.109741_bb0760","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12977-019-0477-y","article-title":"CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4+ T cells and hematopoietic stem\/progenitor cells promotes HIV-1 resistance and CD4+ T cell enrichment in humanized mice","volume":"16","author":"Xiao","year":"2019","journal-title":"Retrovirology."},{"key":"10.1016\/j.clim.2023.109741_bb0765","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1089\/crispr.2020.0019","article-title":"Increased efficiency for biallelic mutations of the CCR5 gene by CRISPR-Cas9 using multiple guide RNAs as a novel therapeutic option for human immunodeficiency virus","volume":"4","author":"Lin","year":"2021","journal-title":"CRISPR J."},{"key":"10.1016\/j.clim.2023.109741_bb0770","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.omtm.2020.03.004","article-title":"Experimental treatment of SIV-infected macaques via autograft of CCR5-disrupted hematopoietic stem and progenitor cells","volume":"17","author":"Yu","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.clim.2023.109741_bb0775","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/QAD.0000000000002539","article-title":"Genetically-edited induced pluripotent stem cells derived from HIV-1-infected patients on therapy can give rise to immune cells resistant to HIV-1 infection","volume":"34","author":"Teque","year":"2020","journal-title":"AIDS Lond. Engl."},{"key":"10.1016\/j.clim.2023.109741_bb0780","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12985-021-01501-7","article-title":"Combination gene therapy for HIV using a conditional suicidal gene with CCR5 knockout","volume":"18","author":"Mehmetoglu-Gurbuz","year":"2021","journal-title":"Virol. J."},{"key":"10.1016\/j.clim.2023.109741_bb0785","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.stemcr.2022.03.003","article-title":"Generation of SIV-resistant T cells and macrophages from nonhuman primate induced pluripotent stem cells with edited CCR5 locus","volume":"17","author":"D'Souza","year":"2022","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.clim.2023.109741_bb0790","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.821190","article-title":"Biallelic, Selectable, Knock-in Targeting of CCR5 via CRISPR-Cas9 Mediated Homology Directed Repair Inhibits HIV-1 Replication","volume":"13","author":"Scheller","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2023.109741_bb0795","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.omtm.2022.01.012","article-title":"CRISPR-Cas9-mediated gene disruption of HIV-1 co-receptors confers broad resistance to infection in human T cells and humanized mice","volume":"24","author":"Li","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623005041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623005041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:09:48Z","timestamp":1761494988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661623005041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":152,"alternative-id":["S1521661623005041"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2023.109741","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiretrovirals to CCR5 CRISPR\/Cas9 gene editing - A paradigm shift chasing an HIV cure","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2023.109741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109741"}}